Indiana life sciences companies capture more venture capital money in first half of 2010
Venture dollars for Hoosier companies are still few, but the flow of deals is picking up.
Health Care & Life Sciences
Articles
Hill-Rom raises profit forecast after quarterly earnings jump
The Batesville-based maker of hospital beds and furniture announced Wednesday night that it earned $30.6 million in its third quarter, up from $20.2 million in the same quarter of 2009.
Investors fear insurers’ rosy outlook will boost regulators’ scrutiny
Indianapolis-based WellPoint Inc. became the third U.S. health insurer this month to increase its 2010 profit forecast, stirring
investor concern that state and federal regulators may increase scrutiny of industry pricing.
Lilly loses appeal over patent for cancer drug Gemzar
A U.S. appeals court Wednesday said a lower court was correct to invalidate a patent on the medicine that expires in 2013.
Gemzar generated $1.36 billion in global sales in 2009.
WellPoint gains confidence as profits rise
The Indianapolis-based health insurer raised its full-year profit forecast after it earned $722.4 million, 4 percent higher
than during the same quarter a year ago. Revenue and health plan membership fell.
Exchanges sprout around the country
When the Indiana Health Information Exchange launched in 2004, it was one of nine truly operational exchanges around the country.
Today, the Indianapolis-based organization is one of 73, according to the latest national survey by the eHealth Initiative.
Life sciences deals pick up momentum
Venture dollars for Indiana life sciences companies are still few, but the flow of deals is picking up. Nine Hoosier companies
scored investments totaling $10.4 million during the first six months of the year.
Survey: Many hospital patients in dark about debt-relief options
Marion County survey finds 80 percent of respondents in debt to local hospitals, with about half saying they were never informed
about the availability
of charity care or payment plans.
Local investors make big bet on senior housing
With the first baby boomers set to turn 65 in six months, investments in senior housing are heating up. A group of Indianapolis-area
professionals—including Mark Waterfill (left) and Tony Schantz—have banded together to launch three senior housing
projects around the state, spending $49 million and looking
to do more.
UPDATE: Patent expirations overshadow Lilly profits
Investors are focused on whether Eli Lilly and Co. can continue dividend payments when patent expirations hit in the new few
years and whether the company's drug development pipeline can replace lost revenue.
Lilly’s second-quarter profits surge 16 percent
Indianapolis-based drugmaker Eli Lilly and Co. recorded profits of $1.3 billion, or $1.22 per share, during the three months
ended June 30,
even after paying $27 million in severance to laid off employees.
Lilly completes $180 million acquisition of Alnara
Massachusetts-based Alnara Pharmaceuticals Inc. is a privately held company
developing an enzyme-replacement therapy for disorders of the pancreas.
New rules raise stakes for Lilly drug
Drugmakers testing experimental Alzheimer’s medicines—including Eli Lilly and Co.—got good news last week
when the National Institute on Aging and the Alzheimer’s Association proposed new guidelines to make earlier diagnoses
of the disease.
Indiana Medicaid chief: Feds leave states in dark
Indiana and other states face a struggle as they grapple with putting the health care changes into place in a relatively short
span of time while they also contend with the economic downtown and strained state budgets.
Hospitals map out ways to bypass insurers
Clarian Health is launching its own health insurance plan, the boldest of several initiatives at Indianapolis hospitals to
bypass health insurers and provide health benefits directly to employers.
Lilly reveals plans to cut 340 IT jobs
The Indianapolis-based drugmaker eliminated 140 information technology jobs in June through retirements, resignations and some cuts. Another 115
cuts will be made this month, and the remainder by the end of the year.
Health care reform means changes for Indiana employers
Nearly four months after President Barack Obama signed a health reform bill into law, businesses are still grappling with its
impact on the health benefits they offer their employees.
Lilly’s Alzheimer’s gamble takes aim at $10 billion in patent losses
Both of Lilly’s late-stage treatments are designed to reduce plaque in the brain called beta amyloid, thought by researchers
to be a main contributor to Alzheimer’s. A drug that stops or reduces memory loss caused by Alzheimer’s may be worth more
than $5 billion
a year, an analyst says, helping Lilly overcome the coming patent losses on several important pharmaceuticals.
Lilly to cut 170 manufacturing jobs by year’s end
Eli Lilly and Co. will cut 170 jobs—mostly in Indianapolis—from its manufacturing and quality division by the
end of the year as it continues its efforts to slim down before losing revenue from patent expirations on its bestselling
drugs.
Medical device maker plans Warsaw expansion
Biomet could add about 280 jobs with the $26 million project, which would lead to some manufacturing being transferred from
New Jersey.